Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 2;17(2):e0261350.
doi: 10.1371/journal.pone.0261350. eCollection 2022.

mRNA Covid-19 vaccines in pregnancy: A systematic review

Nando Reza Pratama  1 , Ifan Ali Wafa  1 , David Setyo Budi  1 , Manesha Putra  2 , Manggala Pasca Wardhana  3 , Citrawati Dyah Kencono Wungu  4   5
Affiliations

mRNA Covid-19 vaccines in pregnancy: A systematic review

Nando Reza Pratama et al. PLoS One. .

Abstract

Objective: Pregnancy is a known risk factor for severe Coronavirus disease 2019. It is important to develop safe vaccines that elicit strong maternal and fetal antibody responses.

Methods: Registries (ClinicalTrials.gov, the WHO Clinical Trial Registry, and the European Union Clinical Trial Registry) and databases (MEDLINE, ScienceDirect, Cochrane Library, Proquest, Springer, medRxiv, and bioRxiv) were systematically searched in June 20-22, 2021, for research articles pertaining to Covid-19 and pregnancy. Manual searches of bioRxiv and medRxiv were also conducted. Inclusion criteria were studies that focused on Covid-19 vaccination among pregnant women, while review articles and non-human studies were excluded. Infection rate, maternal antibody response, transplacental antibody transfer, and adverse events were described.

Results: There were 13 observational studies with a total of 48,039 pregnant women who received mRNA vaccines. Of those, three studies investigated infection rate, six studies investigated maternal antibody response, seven studies investigated antibody transfer, three studies reported local adverse events, and five studies reported systemic adverse events. The available data suggested that the mRNA-based vaccines (Pfizer-BioNTech and Moderna) can prevent future SARS-CoV-2 infection. These vaccines did not show clear harm in pregnancy. The most commonly encountered adverse reactions were pain at the injection site, fatigue, and headache, but these were transient. Antibody responses were rapid after the first vaccine dose. After the booster, antibody responses were stronger and associated with better transplacental antibody transfer. Longer intervals between first vaccination dose and delivery were also associated with higher antibody fetal IgG and a better antibody transfer ratio.

Conclusions: The SARS-CoV-2 mRNA vaccines are encouraged for pregnancy. These vaccines can be a safe option for pregnant women and their fetuses. Two vaccine doses are recommended for more robust maternal and fetal antibody responses. Longer latency is associated with higher fetal antibody responses. Further research about its long-term effect on pregnancy is needed.

Systematic review registration: PROSPERO (CRD42021261684).

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. PRISMA flow diagram of study selection process.
See this image and copyright information in PMC

Comment in

References

    1. Van Spall HGC. Exclusion of pregnant and lactating women from COVID-19 vaccine trials: a missed opportunity. Eur Heart J. 2021;4: ehab103. doi: 10.1093/eurheartj/ehab103 - DOI - PMC - PubMed
    1. Dashraath P, Wong JLJ, Lim MXK, Lim LM, Li S, Biswas A, et al.. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol. 2020;222(6): 521–531. doi: 10.1016/j.ajog.2020.03.021 - DOI - PMC - PubMed
    1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223): 497–506. doi: 10.1016/S0140-6736(20)30183-5 - DOI - PMC - PubMed
    1. Zambrano LD, Ellington S, Strid P, Galang RR, Oduyebo T, Tong VT, et al.. Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status-United States, January 22-October 3, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(44): 1641–1647. doi: 10.15585/mmwr.mm6944e3 - DOI - PMC - PubMed
    1. Gray KJ, Bordt EA, Atyeo C, Deriso E, Akinwunmi B, Young N, et al.. Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study. Am J Obstet Gynecol. 2021;26: S0002-9378(21)00187-3. doi: 10.1016/j.ajog.2021.03.023 - DOI - PMC - PubMed

Publication types

MeSH terms